Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report

INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...

Descripción completa

Detalles Bibliográficos
Autores principales: Dao, Abou, Benchakroun, Nadia, Jabir, Hamza, Taleb, Amina, Bouchbika, Zineb, Tawfiq, Nezha, Jouhadi, Hassan, Sahraoui, Souha, Benider, Abdellatif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307220/
https://www.ncbi.nlm.nih.gov/pubmed/25488584
http://dx.doi.org/10.1186/1752-1947-8-416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307220/
https://www.ncbi.nlm.nih.gov/pubmed/25488584
http://dx.doi.org/10.1186/1752-1947-8-416

Ejemplares similares